Induction of Tolerance in Murine Autoimmune Diabetes by Transient Blockade of LFA-1/ICAM-1 Pathway
Induction of Tolerance in Murine Autoimmune Diabetes by Transient Blockade of LFA-1/ICAM-1 Pathway
批准号:
05670864
负责人:
AMANO Kazuhiko
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
本研究表明,在关键时期短期给予针对白细胞功能相关抗原-1 (LFA-1)和细胞间粘附分子-1 (ICAM-1)的单克隆抗体可完全保护非肥胖糖尿病(NOD)小鼠的自身免疫性糖尿病。当这些单克隆抗体在2周龄时仅给药6天时,在30周龄时未观察到糖尿病或胰岛素。对β细胞Ag(s)的耐受性似乎是由LFA-1/ICAM-1通路的短暂阻断诱导的。保护性抑制活性不足以预防糖尿病,因为在2周龄时接受这些单克隆抗体的雌性NOD小鼠的脾细胞共同转移,只会导致急性糖尿病NOD小鼠的脾细胞过过性转移引起的糖尿病发作的短暂延迟。将这些脾细胞移植到年轻NOD小鼠身上也不能消除自发性糖尿病和胰岛素炎。此外,环磷酰胺处理不能消除保护作用。当将NOD小鼠的脾细胞转移到NOD- scid小鼠身上时,没有一只受体小鼠出现明显的胰岛素炎和随后的显性糖尿病,这表明糖尿病效应T细胞的缺失或失活。然而,接受单抗治疗的无胰岛素NOD小鼠的脾T细胞在体外对胰岛细胞和65-kDa谷氨酸脱羧酶(GAD65)均保持了增殖反应。这些结果表明,在早期NOD小鼠中,LFA-1/ICAM-1通路的短暂阻断诱导了独特的外周耐受性。
英文摘要
The present study demonstrated that a short-term administration of mAbs against leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) at critical periods resulted in complete protection of autoimmune diabetes in non-obese diabetic (NOD) mice. When these mAbs were administered for only 6 days at 2 wk of age, neither diabetes nor insulitis was observed at 30 wk of age. It appears that the tolerance against beta cell Ag(s) was induced by this transient blockade of the LFA-1/ICAM-1 pathway. Protective suppressor activity was not enough to prevent diabetes because co-transfer of splenocytes from female NOD mice, which had received these mAbs at 2wk of age, resulted in only a short delay of the diabetic onset caused by adoptive transfer of splenocytes from acutely diabetic NOD mice. Transfer of these splenocytes to young NOD mice could not also abrogate the spontaneous diabetes and insulitis. Furthermore, cyclophosphamide treatment could not abrogate the protection. 'When splenocytes from the treated NOD mice were transferred to NOD-SCID mice, none of the recipient mice developed significant insulitis and subsequent overt diabetes, suggesting the absence or the inactivation of diabetogenic effector T cells. However, splenic T cells from the insulitis-free NOD mice that had received the mAb treatment preserved proliferative responses to both islet cells and 65-kDa glutamic acid decarboxylase (GAD65) in vitro. These results suggest that a unique peripheral tolerance was induced by the transient blockade of the LFA-1/ICAM-1 pathway in an early age of NOD mice.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
八木規夫: "NODマウス膵臓におけるICAMの発現" Diabetes Frontier. Vol.4,No4. 467 (1993)
Norio Yagi:“NOD 小鼠胰腺中 ICAM 的表达”《糖尿病前沿》第 4 卷,第 467 期(1993 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
天野和彦: "NODマウスにおける接着分子の関与と発症予防への応用" 糖尿病記録号1993. 95-100 (1994)
Kazuhiko Amano:“NOD 小鼠中粘附分子的参与及其在疾病预防中的应用”糖尿病记录号 1993. 95-100 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
長谷川 裕: "NODマウス糖尿病の発症予防に関する研究" Diabetes Frontier. Vol.4,No4. 468-469 (1993)
Yutaka Hasekawa:“NOD 小鼠预防糖尿病的研究”糖尿病前沿,第 4 卷,第 468-469 期(1993 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hasegawa Y,Amano K et al.: "Prevention of Autoimmune Insulin-dependent Diabetes in NOD Mice by Anti-LFA-1 and Anti-ICAM-1 Monoclonal Antibodies." International Immunology. 6. 831-838 (1994)
Hasekawa Y、Amano K 等人:“通过抗 LFA-1 和抗 ICAM-1 单克隆抗体预防 NOD 小鼠自身免疫胰岛素依赖性糖尿病”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
天野和彦,他: "自己免疫性臓器炎の治療(I型糖尿病モデル)-抗接着分子抗体による免疫学的寛容の誘導-." 臨床免疫. 27. 33-39 (1995)
Kazuhiko Amano 等人:“自身免疫性器官炎的治疗(I 型糖尿病模型)- 抗粘附分子抗体诱导免疫耐受。” 临床免疫学 27. 33-39 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
海外基金